Table 4.
Summary of pharmacokinetic parameters derived from (R)-and (S)-salbutamol 4,O-sulphate plasma and urine concentrations in 15 healthy subjects. Data are geometric means (95% CI).

Summary of pharmacokinetic parameters derived from (R)-and (S)-salbutamol 4,O-sulphate plasma and urine concentrations in 15 healthy subjects. Data are geometric means (95% CI).
